Interleukin-5, a therapeutic target in allergic inflammation.
Huston
D P
DP
Department of Medicine, Baylor College of Medicine, Houston, Texas 77030, USA.
Huston
M M
MM
Dickason
R R
RR
Martinez-Moczygemba
M
M
D000818:Animals; D001249:Asthma / Q000209:etiology / Q000628:therapy; D004804:Eosinophils / Q000276:immunology; D006801:Humans; D006967:Hypersensitivity / Q000209:etiology / Q000628:therapy*; D007249:Inflammation / Q000209:etiology / Q000628:therapy*; D015848:Interleukin-5 / Q000737:chemistry / Q000235:genetics / Q000502:physiology*; D008958:Models, Molecular; D020033:Protein Isoforms / Q000737:chemistry / Q000235:genetics / Q000502:physiology; D017434:Protein Structure, Tertiary; D018123:Receptors, Interleukin / Q000737:chemistry / Q000235:genetics / Q000502:physiology; D053649:Receptors, Interleukin-5; D015398:Signal Transduction
D015848:Interleukin-5; D020033:Protein Isoforms; D018123:Receptors, Interleukin; D053649:Receptors, Interleukin-5